Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2.53M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
-5.9M
-
Total reported value, excl. options
-
$10.1M
-
Value change
-
-$3.27M
-
Put/Call ratio
-
0
-
Number of buys
-
10
-
Number of sells
-
-34
-
Price
-
$0.38
Significant Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q3 2023
61 filings reported holding OMIC - Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value as of Q3 2023.
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4.98M shares), ARCH Venture Management, LLC (3.8M shares), PERCEPTIVE ADVISORS LLC (2.36M shares), UBS Group AG (2.21M shares), FMR LLC (2.12M shares), VANGUARD GROUP INC (1.89M shares), Casdin Capital, LLC (1.32M shares), QVIDTVM Management LLC (1.19M shares), BlackRock Inc. (866K shares), and MILLENNIUM MANAGEMENT LLC (712K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.